DIPRIVAN Side Effects

7007234-0 | Hepatitis Acute, Pyrexia
on Sep 13, 2010 Male patient from FRANCE , 59 years of age, was diagnosed with anaesthesia and was treated with Diprivan (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis acute, pyrexia. Diprivan dosage: . Patient was hospitalized.

6992333-X | Circulatory Collapse
Patient was taking Diprivan (View Usage). Patient had the following side effects: circulatory collapse on Sep 14, 2010 from FRANCE Additional patient health information: Female patient , weighting 154.3 lb, was diagnosed with induction of anaesthesia, antibiotic prophylaxis and. Diprivan dosage: . During the same period patient was treated with TRACRIUM (View Tracrium Review and Tracrium Label ), ULTIVA (View Ultiva Review and Ultiva Label ), AUGMENTIN '125' (3 G Once (2 G Then 1 G)) (View Augmentin '125' Review and Augmentin '125' Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), TAREG (View Tareg Review and Tareg Label ), EZETIMIBE/SIMVASTATIN (View Ezetimibe/simvastatin Review and Ezetimibe/simvastatin Label ), ALFUZOSIN HCL (View Alfuzosin Hcl Review and Alfuzosin Hcl Label ).

6976279-9 | Blood Creatine Phosphokinase Increased, Pyrexia
Adverse event was reported on Sep 03, 2010 by a Male patient taking Diprivan (View Usage) (Dosage: ) was diagnosed with induction and maintenance of anaesthesia, induction of anaesthesia, epidural anaesthesia and. Location: JAPAN , 55 years of age, weighting 172.0 lb, After Diprivan was administered, patient had the following side effects: blood creatine phosphokinase increased, pyrexia. During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), ATROPINE (View Atropine Review and Atropine Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), VECURONIUM BROMIDE (Induction 10 Ml + Additional Injection: Total 19 Ml) (View Vecuronium Bromide Review and Vecuronium Bromide Label ), LIDOCAINE (1.5 % 7 Ml + 1 % 5 Ml/hr Continuously) (View Lidocaine Review and Lidocaine Label ).

6967260-4 | Electrocardiogram Qt Prolonged, Torsade De Pointes
on Aug 23, 2010 Male patient from JAPAN , weighting 154.3 lb, was diagnosed with sedation, endocarditis (What is endocarditis?) and was treated with Diprivan (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged, torsade de pointes. Diprivan dosage: . During the same period patient was treated with RASENAZOLIN (View Rasenazolin Review and Rasenazolin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), OMEPRAL INJECTION (View Omepral Injection Review and Omepral Injection Label ), ELASPOL (View Elaspol Review and Elaspol Label ), BUMINATE (View Buminate Review and Buminate Label ), ALBUMINAR (View Albuminar Review and Albuminar Label ).


6963075-1 | Blood Creatine Phosphokinase Increased, Pyrexia
on Aug 26, 2010 Male patient from JAPAN , 55 years of age, weighting 172.0 lb, was diagnosed with induction and maintenance of anaesthesia, induction of anaesthesia, epidural anaesthesia and was treated with Diprivan (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, pyrexia. Diprivan dosage: . During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), ATROPINE (View Atropine Review and Atropine Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), VECURONIUM BROMIDE (Induction 10 Ml + Additional Injection: Total 19 Ml) (View Vecuronium Bromide Review and Vecuronium Bromide Label ), LIDOCAINE (1.5 % 7 Ml + 1 % 5 Ml/hr Continuously) (View Lidocaine Review and Lidocaine Label ).

6944804-X | Hypercreatinaemia, Pyrexia
Patient was taking Diprivan (View Usage). After Diprivan was administered, patient had the following side effects: hypercreatinaemia, pyrexia on Aug 18, 2010 from JAPAN Additional patient health information: Male patient , 55 years of age, weighting 172.0 lb, was diagnosed with induction and maintenance of anaesthesia, induction of anaesthesia, epidural anaesthesia and. Diprivan dosage: . During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), ATROPINE (View Atropine Review and Atropine Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), VECURONIUM BROMIDE (Induction 10 Ml + Additional Injection: Total 19 Ml) (View Vecuronium Bromide Review and Vecuronium Bromide Label ), LIDOCAINE (1.5 % 7 Ml + 1 % 5 Ml/hr Continuously) (View Lidocaine Review and Lidocaine Label ).

6910257-0 | Neuroleptic Malignant Syndrome
Adverse event was reported on Aug 02, 2010 by a Female patient taking Diprivan (View Usage) (Dosage: ) was diagnosed with sedation, infection (What is infection?), shock and. Location: JAPAN , 47 years of age, Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome. During the same period patient was treated with PRECEDEX (View Precedex Review and Precedex Label ), SERENACE (View Serenace Review and Serenace Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ZOSYN (View Zosyn Review and Zosyn Label ), TARGOCID (View Targocid Review and Targocid Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), ADRENAL HORMONE PREPARATIONS (View Adrenal Hormone Preparations Review and Adrenal Hormone Preparations Label ), POLYGAM S/D (View Polygam S/d Review and Polygam S/d Label ).

6907648-0 | Cholestasis, Confusional State, Hepatic Enzyme Increased, Jaundice
on Jul 22, 2010 Male patient from FRANCE , 75 years of age, was diagnosed with induction of anaesthesia, nerve block, postoperative analgesia, thrombosis prophylaxis and was treated with Diprivan (View Usage). Patient had the following side effects: cholestasis, confusional state, hepatic enzyme increased, jaundice (What is jaundice?). Diprivan dosage: Single Administration. During the same period patient was treated with NAROPIN (View Naropin Review and Naropin Label ), MORPHINE (View Morphine Review and Morphine Label ), XARELTO (View Xarelto Review and Xarelto Label ), SEVORANE (Single Administration) (View Sevorane Review and Sevorane Label ), SUFENTANIL (Single Administration) (View Sufentanil Review and Sufentanil Label ), PROFENID (View Profenid Review and Profenid Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), CEFAMANDOLE PANPHARMA (View Cefamandole Panpharma Review and Cefamandole Panpharma Label ).

6895981-0 | Delayed Recovery From Anaesthesia
on Jul 22, 2010 Male patient from JAPAN , 41 years of age, weighting 280.0 lb, was diagnosed with sedation and was treated with Diprivan (View Usage). After Diprivan was administered, patient had the following side effects: delayed recovery from anaesthesia. Diprivan dosage: 270 Mg/h.

6894731-1 | Atrial Fibrillation, Respiratory Arrest
Patient was taking Diprivan (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), respiratory arrest on Jul 28, 2010 from CHINA Additional patient health information: Male patient , 63 years of age, was diagnosed with endoscopy upper gastrointestinal tract and. Diprivan dosage: 4 Mg/s, When 200 Mg Was Given.

6894659-7 | Cholestasis, Confusional State, Hepatic Enzyme Increased, Jaundice
Adverse event was reported on Jul 22, 2010 by a Male patient taking Diprivan (View Usage) (Dosage: Single Administration) was diagnosed with induction of anaesthesia, nerve block, postoperative analgesia, thrombosis prophylaxis and. Location: FRANCE , 75 years of age, Patient had the following side effects: cholestasis, confusional state, hepatic enzyme increased, jaundice (What is jaundice?). During the same period patient was treated with NAROPIN (View Naropin Review and Naropin Label ), MORPHINE (View Morphine Review and Morphine Label ), XERALTO (View Xeralto Review and Xeralto Label ), SEVORANE (Single Administration) (View Sevorane Review and Sevorane Label ), SUFENTANIL (Single Administration) (View Sufentanil Review and Sufentanil Label ), PROFENID (View Profenid Review and Profenid Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), CEFAMANDOLE PANPHARMA (View Cefamandole Panpharma Review and Cefamandole Panpharma Label ).

6875650-3 | Propofol Infusion Syndrome
on Jul 16, 2010 Male patient from JAPAN , 50 years of age, was treated with Diprivan (View Usage). After Diprivan was administered, patient had the following side effects: propofol infusion syndrome. Diprivan dosage: .

6871398-X | Anaphylactic Shock
on Jul 22, 2010 Female patient from FRANCE , 55 years of age, was diagnosed with anaesthesia and was treated with Diprivan (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock. Diprivan dosage: . During the same period patient was treated with SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), TRACRIUM (View Tracrium Review and Tracrium Label ), KETALAR (View Ketalar Review and Ketalar Label ), HYPNOVEL (View Hypnovel Review and Hypnovel Label ), MONO ALGIC (View Mono-algic Review and Mono-algic Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ).

6861147-3 | Blood Pressure Decreased, Respiratory Arrest
Patient was taking Diprivan (View Usage). Patient had the following side effects: blood pressure decreased, respiratory arrest on Jul 15, 2010 from CHINA Additional patient health information: Female patient , 17 years of age, weighting 110.2 lb, was diagnosed with abortion induced and. Diprivan dosage: .

6861145-X | Respiratory Arrest
Adverse event was reported on Jul 15, 2010 by a Female patient taking Diprivan (View Usage) (Dosage: ) . Location: CHINA , 26 years of age, weighting 132.3 lb, After Diprivan was administered, patient had the following side effects: respiratory arrest.

6856670-1 | Cardiogenic Shock
on Jul 15, 2010 Female patient from JAPAN , 39 years of age, weighting 92.59 lb, was diagnosed with induction of anaesthesia, maintenance of anaesthesia and was treated with Diprivan (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock. Diprivan dosage: . During the same period patient was treated with SEVOFLURANE (7%) (View Sevoflurane Review and Sevoflurane Label ), NITROUS OXIDE_OXYGEN (40%) (View Nitrous Oxide_oxygen Review and Nitrous Oxide_oxygen Label ), METHOXAMINE HYDROCHLORIDE (1mg ~17 Mg) (View Methoxamine Hydrochloride Review and Methoxamine Hydrochloride Label ).

6855847-9 | Delayed Recovery From Anaesthesia
on Jul 12, 2010 Male patient from JAPAN , 41 years of age, weighting 280.0 lb, was diagnosed with sedation and was treated with Diprivan (View Usage). Patient had the following side effects: delayed recovery from anaesthesia. Diprivan dosage: 270 Mg/h.

6843551-2 | Rhabdomyolysis
Patient was taking Diprivan (View Usage). After Diprivan was administered, patient had the following side effects: rhabdomyolysis on Jul 07, 2010 from JAPAN Additional patient health information: Male patient , 43 years of age, was diagnosed with sedation and. Diprivan dosage: .

6835626-9 | Neuroleptic Malignant Syndrome
Adverse event was reported on Jul 05, 2010 by a Female patient taking Diprivan (View Usage) (Dosage: ) was diagnosed with sedation, infection (What is infection?), shock, rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 47 years of age, Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome. During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), DEXMEDETOMIDINE HYDROCHLORIDE (View Dexmedetomidine Hydrochloride Review and Dexmedetomidine Hydrochloride Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), ADRENAL HORMONE PREPARATIONS (View Adrenal Hormone Preparations Review and Adrenal Hormone Preparations Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), POLYGAM S/D (View Polygam S/d Review and Polygam S/d Label ). Patient was hospitalized.

6826062-X | Neuroleptic Malignant Syndrome
on Jun 30, 2010 Female patient from JAPAN , 47 years of age, was diagnosed with sedation, infection (What is infection?), shock, rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Diprivan (View Usage). Patient had the following side effects: neuroleptic malignant syndrome. Diprivan dosage: . During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), DEXMEDETOMIDINE HYDROCHLORIDE (View Dexmedetomidine Hydrochloride Review and Dexmedetomidine Hydrochloride Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), ADRENAL HORMONE PREPARATIONS (View Adrenal Hormone Preparations Review and Adrenal Hormone Preparations Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), POLYGAM S/D (View Polygam S/d Review and Polygam S/d Label ).

6819454-6 | Anaphylactic Shock
on Jul 05, 2010 Male patient from FRANCE , 64 years of age, was diagnosed with induction of anaesthesia, antibiotic prophylaxis, type 2 diabetes mellitus, pancreatitis and was treated with Diprivan (View Usage). After Diprivan was administered, patient had the following side effects: anaphylactic shock. Diprivan dosage: . During the same period patient was treated with SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), SEVORANE (View Sevorane Review and Sevorane Label ), AMAREL (View Amarel Review and Amarel Label ), LEVEMIR (View Levemir Review and Levemir Label ), CREON (View Creon Review and Creon Label ). Patient was hospitalized.

6817768-7 | Bronchospasm, Circulatory Collapse
Patient was taking Diprivan (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, circulatory collapse on Jun 22, 2010 from FRANCE Additional patient health information: Female patient , 52 years of age, was diagnosed with induction of anaesthesia and. Diprivan dosage: . During the same period patient was treated with CELOCURINE (View Celocurine Review and Celocurine Label ), SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ).

6802762-2 | Bronchospasm, Circulatory Collapse
Adverse event was reported on Jun 22, 2010 by a Female patient taking Diprivan (View Usage) (Dosage: ) was diagnosed with induction of anaesthesia and. Location: FRANCE , 52 years of age, Patient had the following side effects: bronchospasm, circulatory collapse. During the same period patient was treated with CELOCURINE (View Celocurine Review and Celocurine Label ), SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ).

6802761-0 | Bronchospasm, Circulatory Collapse, Rash
on Jun 22, 2010 Female patient from FRANCE , 57 years of age, was diagnosed with induction of anaesthesia and was treated with Diprivan (View Usage). After Diprivan was administered, patient had the following side effects: bronchospasm, circulatory collapse, rash (What is rash?). Diprivan dosage: . During the same period patient was treated with CELOCURINE (View Celocurine Review and Celocurine Label ).

6802738-5 | Bronchospasm, Hypotension, Tachycardia, Vasoplegia Syndrome
on Jun 22, 2010 Male patient from FRANCE , weighting 19.62 lb, was treated with Diprivan (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, hypotension, tachycardia, vasoplegia syndrome. Diprivan dosage: . During the same period patient was treated with TRACRIUM (View Tracrium Review and Tracrium Label ), ATROPINE (150 (unit Not Specified)) (View Atropine Review and Atropine Label ), HEXABRIX (View Hexabrix Review and Hexabrix Label ), SUFENTA PRESERVATIVE FREE (2.5 (unit Not Specified)) (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ).

6781914-4 | Anaphylactic Shock
Patient was taking Diprivan (View Usage). Patient had the following side effects: anaphylactic shock on Jun 15, 2010 from FRANCE Additional patient health information: Male patient , 64 years of age, was diagnosed with induction of anaesthesia, antibiotic prophylaxis, type 2 diabetes mellitus, pancreatitis and. Diprivan dosage: . During the same period patient was treated with SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), AMAREL (View Amarel Review and Amarel Label ), LEVEMIR (View Levemir Review and Levemir Label ), CREON (View Creon Review and Creon Label ), SEVORANE (View Sevorane Review and Sevorane Label ). Patient was hospitalized.

6768473-7 | Anaphylactic Shock
Adverse event was reported on Jun 10, 2010 by a Female patient taking Diprivan (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: FRANCE , 55 years of age, After Diprivan was administered, patient had the following side effects: anaphylactic shock. During the same period patient was treated with SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), TRACRIUM (View Tracrium Review and Tracrium Label ), KETALAR (View Ketalar Review and Ketalar Label ), HYPNOVEL (View Hypnovel Review and Hypnovel Label ), MONO ALGIC (View Mono-algic Review and Mono-algic Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ).

6767639-X | Off Label Use, Propofol Infusion Syndrome
on Jun 08, 2010 Female patient from FRANCE , 17 years of age, weighting 121.3 lb, was diagnosed with convulsion, sedation and was treated with Diprivan (View Usage). Patient experienced the following unwanted or unexpected effects: off label use, propofol infusion syndrome. Diprivan dosage: . During the same period patient was treated with MIDAZOLAM (View Midazolam Review and Midazolam Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ).

6765658-0 | Anaphylactic Shock
on Jun 09, 2010 Female patient from FRANCE , 55 years of age, was treated with Diprivan (View Usage). Patient had the following side effects: anaphylactic shock. Diprivan dosage: Single Administration. During the same period patient was treated with SUFENTA PRESERVATIVE FREE (Single Administration) (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), TRACRIUM (Single Administration) (View Tracrium Review and Tracrium Label ), KETALAR (View Ketalar Review and Ketalar Label ).

6760387-1 | Rhabdomyolysis
Patient was taking Diprivan (View Usage). After Diprivan was administered, patient had the following side effects: rhabdomyolysis on Jun 04, 2010 from JAPAN Additional patient health information: Female patient , child 1 years of age, . Diprivan dosage: .

6755535-3 | Circulatory Collapse
Adverse event was reported on Jun 02, 2010 by a Female patient taking Diprivan (View Usage) (Dosage: ) was diagnosed with induction of anaesthesia and. Location: FRANCE , 69 years of age, Patient experienced the following unwanted or unexpected effects: circulatory collapse. During the same period patient was treated with CELOCURIN (View Celocurin Review and Celocurin Label ), ULTIVA (View Ultiva Review and Ultiva Label ).

6755464-5 | Acute Myocardial Infarction
on Jun 02, 2010 Male patient from JAPAN , 37 years of age, weighting 231.5 lb, was diagnosed with sedation and was treated with Diprivan (View Usage). Patient had the following side effects: acute myocardial infarction. Diprivan dosage: .

6755460-8 | Blood Pressure Decreased, Bradycardia, Respiratory Depression
on May 28, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with induction and maintenance of anaesthesia and was treated with Diprivan (View Usage). After Diprivan was administered, patient had the following side effects: blood pressure decreased, bradycardia, respiratory depression. Diprivan dosage: 30-40 Ml Iv, 1-3 Mg/kg/hr. During the same period patient was treated with DROPERIDOL (2.5 Mg Iv 5 Minutes Before) (View Droperidol Review and Droperidol Label ).

6749845-3 | Propofol Infusion Syndrome
Patient was taking Diprivan (View Usage). Patient experienced the following unwanted or unexpected effects: propofol infusion syndrome on May 24, 2010 from JAPAN Additional patient health information: Male patient , 50 years of age, . Diprivan dosage: .

6749519-9 | Rhabdomyolysis
Adverse event was reported on May 25, 2010 by a Male patient taking Diprivan (View Usage) (Dosage: ) was diagnosed with maintenance of anaesthesia, induction of anaesthesia, induction and maintenance of anaesthesia and. Location: JAPAN , child 4 years of age, Patient had the following side effects: rhabdomyolysis. During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ESLAX (View Eslax Review and Eslax Label ).

6741126-7 | Excessive Sexual Fantasies
on May 17, 2010 Female patient from FRANCE , 60 years of age, was diagnosed with anaesthesia and was treated with Diprivan (View Usage). After Diprivan was administered, patient had the following side effects: excessive sexual fantasies. Diprivan dosage: . During the same period patient was treated with SUFENTANIL (View Sufentanil Review and Sufentanil Label ), TRACRIUM (View Tracrium Review and Tracrium Label ), NAROPIN (View Naropin Review and Naropin Label ).

6718675-0 | Dyspnoea, Incorrect Dose Administered
on Apr 22, 2010 Female patient from UNITED STATES , child 6 years of age, was diagnosed with sedation and was treated with Diprivan (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, incorrect dose administered. Diprivan dosage: 5 Mg Ordered, 50 Mg Given, Inhalation.

6711282-5 | Circulatory Collapse
Patient was taking Diprivan (View Usage). Patient had the following side effects: circulatory collapse on May 03, 2010 from FRANCE Additional patient health information: Female patient , 74 years of age, weighting 154.3 lb, was diagnosed with induction of anaesthesia, antibiotic prophylaxis and. Diprivan dosage: . During the same period patient was treated with CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), TRACRIUM (View Tracrium Review and Tracrium Label ), DI ANTALVIC (View Di Antalvic Review and Di Antalvic Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), LEXOMYL (View Lexomyl Review and Lexomyl Label ), STRESAM (View Stresam Review and Stresam Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ).

6700393-6 | Circulatory Collapse
Adverse event was reported on Apr 26, 2010 by a Female patient taking Diprivan (View Usage) (Dosage: ) was diagnosed with induction of anaesthesia, antibiotic prophylaxis and. Location: FRANCE , 74 years of age, weighting 154.3 lb, After Diprivan was administered, patient had the following side effects: circulatory collapse. During the same period patient was treated with CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), TRACRIUM (View Tracrium Review and Tracrium Label ), DI ANTALVIC (View Di Antalvic Review and Di Antalvic Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), LEXOMYL (View Lexomyl Review and Lexomyl Label ), STRESAM (View Stresam Review and Stresam Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ).

6700265-7 | Atrioventricular Block, Supraventricular Extrasystoles
on Apr 21, 2010 Male patient from JAPAN , 33 years of age, weighting 163.1 lb, was diagnosed with hypotonia and was treated with Diprivan (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block, supraventricular extrasystoles. Diprivan dosage: . During the same period patient was treated with VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ).

6697305-0 | Hyperthermia Malignant, Rhabdomyolysis
on Apr 16, 2010 Male patient from JAPAN , 31 years of age, was treated with Diprivan (View Usage). Patient had the following side effects: hyperthermia malignant, rhabdomyolysis. Diprivan dosage: . During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

6691523-3 | Hyperthermia Malignant, Rhabdomyolysis
Patient was taking Diprivan (View Usage). After Diprivan was administered, patient had the following side effects: hyperthermia malignant, rhabdomyolysis on Apr 16, 2010 from JAPAN Additional patient health information: Male patient , 31 years of age, . Diprivan dosage: . During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

6676919-8 | Dizziness Postural, Eyelid Ptosis, Headache, Lacrimation Increased, Neck Pain, Photophobia
Adverse event was reported on Apr 01, 2010 by a Female patient taking Diprivan (View Usage) (Dosage: Once/single Administration) . Location: FRANCE , 50 years of age, weighting 101.4 lb, Patient experienced the following unwanted or unexpected effects: dizziness postural, eyelid ptosis, headache (What is headache?), lacrimation increased, neck pain, photophobia. During the same period patient was treated with FENTANYL 100 (Once/single Administration) (View Fentanyl-100 Review and Fentanyl-100 Label ), ISOFLURANE (Once/single Administration) (View Isoflurane Review and Isoflurane Label ).

6674656-7 | Hyperthermia Malignant, Rhabdomyolysis
on Apr 06, 2010 Male patient from JAPAN , 31 years of age, was treated with Diprivan (View Usage). Patient had the following side effects: hyperthermia malignant, rhabdomyolysis. Diprivan dosage: .

6673159-3 | Hepatic Function Abnormal
on Mar 31, 2010 Female patient from JAPAN , 76 years of age, weighting 94.80 lb, was diagnosed with sedation and was treated with Diprivan (View Usage). After Diprivan was administered, patient had the following side effects: hepatic function abnormal. Diprivan dosage: 60 Mg; 20-40 Mg/kg/hr. During the same period patient was treated with DEPAS (View Depas Review and Depas Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), PURSENNID (View Pursennid Review and Pursennid Label ), REMINARON (View Reminaron Review and Reminaron Label ), OPYSTAN (View Opystan Review and Opystan Label ). Patient was hospitalized.

6673158-1 | Hepatic Function Abnormal
Patient was taking Diprivan (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal on Mar 31, 2010 from JAPAN Additional patient health information: Female patient , 68 years of age, weighting 121.3 lb, was diagnosed with sedation and. Diprivan dosage: 60 Mg; 20-40 Mg/kg/hr. During the same period patient was treated with REMINARON (View Reminaron Review and Reminaron Label ), OPYSTAN (View Opystan Review and Opystan Label ). Patient was hospitalized.

6671316-3 | Dizziness Postural, Eyelid Ptosis, Headache, Lacrimation Increased, Neck Pain, Photophobia
Adverse event was reported on Apr 01, 2010 by a Female patient taking Diprivan (View Usage) (Dosage: Once/single Administration) . Location: FRANCE , 50 years of age, weighting 101.4 lb, Patient had the following side effects: dizziness postural, eyelid ptosis, headache (What is headache?), lacrimation increased, neck pain, photophobia. During the same period patient was treated with FENTANYL (Once/single Administration) (View Fentanyl Review and Fentanyl Label ), ISOFLURANE (Once/single Administration) (View Isoflurane Review and Isoflurane Label ).

6668805-4 | Pleural Effusion
on Apr 02, 2010 Male patient from JAPAN , 67 years of age, was diagnosed with induction of anaesthesia, maintenance of anaesthesia and was treated with Diprivan (View Usage). After Diprivan was administered, patient had the following side effects: pleural effusion. Diprivan dosage: . During the same period patient was treated with REMIFENTANIL HYDROCHLORIDE (View Remifentanil Hydrochloride Review and Remifentanil Hydrochloride Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

6655490-0 | Bronchospasm, Erythema, Shock
on Mar 24, 2010 Female patient from FRANCE , 32 years of age, was diagnosed with anaesthesia and was treated with Diprivan (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, erythema, shock. Diprivan dosage: . During the same period patient was treated with CELOCURINE (View Celocurine Review and Celocurine Label ), SUFENTANIL (View Sufentanil Review and Sufentanil Label ).

6647974-6 | Gaze Palsy
Patient was taking Diprivan (View Usage). Patient had the following side effects: gaze palsy on Mar 15, 2010 from JAPAN Additional patient health information: Male patient , weighting 145.5 lb, was diagnosed with sedation and. Diprivan dosage: 4-5 Mg/kg/hr, 31680 Mg. During the same period patient was treated with LEPETAN (View Lepetan Review and Lepetan Label ), PERDIPINE (View Perdipine Review and Perdipine Label ), RINDERON (4-8g/day) (View Rinderon Review and Rinderon Label ), RADICUT (View Radicut Review and Radicut Label ), PRECEDEX (View Precedex Review and Precedex Label ), CEFAMEZIN ALPHA (View Cefamezin Alpha Review and Cefamezin Alpha Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ).